PEPTIDE RECEPTOR RADIONUCLIDE THERAPY FOR METASTATIC MEDULLARY THYROID CARCINOMA: A WESTERN AUSTRALIAN EXPERIENCE

被引：0
|
作者：
Pugazhenthi, Kamali [1 ]
机构：
[1] Fiona Stanley Hosp, Murdoch, WA, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2023年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [41] A Case of Metastatic VIPoma With Complete Response to Peptide Radionuclide Receptor Therapy
    Audil, Hadiyah Y.
    Eiring, Rachel A.
    Kendi, A. Tuba
    Halfdanarson, Thorvardur R.
    PANCREAS, 2021, 50 (04) : E45 - E46
  • [42] Peptide receptor radionuclide therapy for treatment of metastatic neuroendocrine tumors in children
    Foster, Jennifer H.
    Sher, Andrew
    Seghers, Victor
    Poston, Jay
    Wells, Donald
    Delpassand, Ebrahim S.
    Potter, Samara
    Mahajan, Priya
    Venkatramani, Rajkumar
    PEDIATRIC BLOOD & CANCER, 2021, 68 (07)
  • [43] Peptide receptor radionuclide therapy
    Teunissen, JJM
    Kwekkeboom, DJ
    de Jong, M
    Esser, JP
    Valkema, R
    Krenning, EP
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2005, 19 (04) : 595 - 616
  • [44] Peptide receptor radionuclide therapy
    Krenning, EP
    Kwekkeboom, DJ
    Valkema, R
    Pauwels, S
    Kvols, LK
    de Jong, M
    GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR DISEASE: MOLECULAR AND CELL BIOLOGICAL ASPECTS, 2004, 1014 : 234 - 245
  • [45] Peptide receptor radionuclide therapy
    Forrer, Flavio
    Valkema, Roelf
    Kwekkeboom, Dik J.
    de Jong, Marion
    Krenning, Eric P.
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 21 (01) : 111 - 129
  • [46] Peptide receptor radionuclide therapy
    Paganelli, Giovanni
    TUMORI, 2010, 96 (05) : 869 - 873
  • [47] Peptide Receptor Radionuclide Therapy
    Hofland, Johannes
    Brabander, Tessa
    Verburg, Frederik A.
    Feelders, Richard A.
    de Herder, Wouter W.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (12): : 3199 - 3208
  • [48] Receptor radionuclide therapy with 90Y-DOTATOC in patients with medullary thyroid carcinomas
    Bodei, L
    Handkiewicz-Junak, D
    Grana, C
    Mazzetta, C
    Rocca, P
    Bartolomei, M
    Sierra, ML
    Cremonesi, M
    Chinol, M
    Mäcke, HR
    Paganelli, G
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2004, 19 (01) : 65 - 71
  • [49] Clinical Efficacy in Treatment of Metastatic Gastrinoma and Glucagonoma with Peptide Receptor Radionuclide Therapy (PRRT) - A Single Centre Experience
    Hung, T. J.
    Michael, M.
    Callahan, J.
    Hicks, R.
    Kong, G.
    NEUROENDOCRINOLOGY, 2019, 108 : 213 - 213
  • [50] Lutetium-177 Dotatate Peptide Receptor Radionuclide Therapy in metastatic pheochromocytoma and paraganglioma: Experience in our center
    Negre, M.
    Guardeno, R.
    Biarnes, J.
    Recasens, M.
    Rubio, A.
    JOURNAL OF NEUROENDOCRINOLOGY, 2024, 36 : 210 - 210
12345